United States· US:66758-241_525ad849-4502-493d-a0a1-67cde0a207f0
Focalin
A dexmethylphenidate product containing dexmethylphenidate hydrochloride, registered in United States by Sandoz Inc. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Dexmethylphenidate is registered in 3 of 19 countries.
Countries holding a registration under ATC N06BA11 (dexmethylphenidate), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Dexmethylphenidate · ATC N06BA11
3 / 19 countries
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dexmethylphenidate costs, country by country.
Normalised to the WHO defined daily dose (15 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dexmethylphenidate · price per daily dose (15 mg)
USD · FX 28 Sept 2026
- CH Switzerland$2.25
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DEXMETHYLPHENIDATE HYDROCHLORIDE
- Manufacturer
- Sandoz Inc
- Country
- United States (US)
- ATC code
- N06BA11
- ATC class
- Dexmethylphenidate
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1166758-241-01
- ndc1166758-241-31
- ndc116675824101100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66758-241-01)
- ndc11667582413130 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66758-241-31)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
53 interactions on record for dexmethylphenidate.
Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dexmethylphenidate · interactions on record
53 records
- 10 severe
- 41 moderate
- 2 minor
Most severe, free to view
- ProcarbazineL01XB01severe
- OzanimodL04AA38severe
- OzanimodL04AE02severe
- CocaineN01BC01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dexmethylphenidate in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fde131b6-35ec-499c-b837-a4c426e51704 GET /v1/drugs/fde131b6-35ec-499c-b837-a4c426e51704?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "35",
"substance": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
"productndc": "66758-241",
"dosage_form": "CAPSULE, EXTENDED RELEASE",
"dea_schedule": "CII",
"strength_unit": "mg/1",
"application_number": "NDA021802",
"marketing_category": "NDA"
}See everything about dexmethylphenidate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.